Cargando…

CD95 ligand expression in dedifferentiated breast cancer

Detalles Bibliográficos
Autores principales:	Moers, C, Müschen, M, Beckmann, MW, Mallmann, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300588/ http://dx.doi.org/10.1186/bcr405

Ejemplares similares

CD95 ligand expression mediates immune escape in breast cancer
por: Moers, C, et al.
Publicado: (2001)

Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene
por: Moers, C, et al.
Publicado: (2001)

The role of CD95 and CD95 ligand in cancer
por: Peter, M E, et al.
Publicado: (2015)

CD95 as a negative or positive costimulatory receptor for primary T cell activation
por: Paulsen, M, et al.
Publicado: (2009)

Dedifferentiated liposarcomas: evaluation of the prognostic and therapeutic factors in the elderly patient
por: Amodeo, C, et al.
Publicado: (2010)

CD31 expression by cells of extensive ductal in situ and invasive carcinomas of the breast
por: Sapino, A, et al.
Publicado: (2001)

Expression of NR1 subunit of NMDA receptor and PSD-93/95 in rat hippocampus affected by NR1/NR2 antisense oligodeoxynucleotide
por: Vrajová, Monika, et al.
Publicado: (2010)

Restored expression of Fhit protein in Fhit-minus breast cancer cells
por: Campiglio, M, et al.
Publicado: (2001)

Ultrasound-guided pO(2) measurement in breast cancer patients before and after hyperthermia treatment
por: Vujaskovic, Z, et al.
Publicado: (2001)

Analysis of Fhit expression in stages of breast cancer progression
por: Campiglio, M, et al.
Publicado: (2000)

Loss of surface CXCR3 expression in the RA synovial CD3 cells as a result of ligand binding suggests the mechanism for increased Th1 cell infiltration
por: Krystufkova, OK, et al.
Publicado: (2002)

CD133-regulated nucleophosmin expression in human colon cancer cells
por: Kim, Kun, et al.
Publicado: (2014)

Telomerase activity and bcl2 expression in human breast cancer
por: Elkak, AE, et al.
Publicado: (2001)

Human platelets stimulate mesangial cells to produce monocyte chemoattractant protein-1 via the CD40/CD40-ligand pathway and may amplify glomerular injury
por: Boumpas, DT, et al.
Publicado: (2003)

CD95 ligand - death factor and costimulatory molecule?
por: Janssen, O, et al.
Publicado: (2003)

In contrast to CD64 expression, CD14 expression is persistently downregulated on polymorphonuclear cells (PMN) but not on monocytes of patients with septic shock
por: Barth, E, et al.
Publicado: (2000)

Differential effect of corticosteroid therapy on the cytoplasmic cytokine expression in CD4 and CD8 positive T cells from lupus patients
por: Kiss, E, et al.
Publicado: (2001)

CD3e expression in HTLV-1-infected individuals is associated with proviral load and Tax expression
por: Pinto, Mariana Tomazini, et al.
Publicado: (2011)

Expression of CD40, CD40L and IgM production in patients with ataxia-telangiectasia
por: Pereira, Camila Teles Machado, et al.
Publicado: (2015)

Serological Her2/neu-determination in patients receiving Herceptin(®)
por: Thomas, A, et al.
Publicado: (2001)

The new B-cell-specific exon 1B of the CD5 mRNA favors autoimmunity by preventing the membrane expression of CD5
por: Renaudineau, Y, et al.
Publicado: (2003)

The association between cyclo-oxygenase-2 expression and cell proliferation and angiogenesis in human breast cancer
por: Kirkpatrick, K, et al.
Publicado: (2001)

Precise Mapping of the CD95 Pre-Ligand Assembly Domain
por: Edmond, Valérie, et al.
Publicado: (2012)

CD95/Fas ligand mRNA is toxic to cells
por: Putzbach, Will, et al.
Publicado: (2018)

Inverse correlation between Tax and CD25 expressions in HTLV-1 infected CD4 T-cells in vivo
por: Tezuka, Kenta, et al.
Publicado: (2011)

Differential expression of Fas receptors (CD95) and Fas ligands (CD95L) in HIV infected and exposed uninfected children in Cameroon versus unexposed children
por: Dambaya, Béatrice, et al.
Publicado: (2019)

Identification of novel ligands interacting with kappa opioid receptors
por: Spetea, Mariana, et al.
Publicado: (2011)

Expression of variant forms of the MUC1 gene correlates with the invasiveness of breast cancer cells
por: Zeillinger, R, et al.
Publicado: (2000)

Relative expression of progesterone receptors A and B in premalignant and invasive breast lesions
por: Mote, P, et al.
Publicado: (2000)

Antiinflammatory Effects of CD95 Ligand (FasL)-induced Apoptosis
por: Gao, Yakun, et al.
Publicado: (1998)

Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy
por: Baeten, D, et al.
Publicado: (2001)

Utilizing CD30 expression as a rational target for therapy of lymphoma
por: Kim, Won Seog
Publicado: (2012)

Gene expression and glycan profiling of CD4+T cells in HAM/TSP
por: Kodama, Daisuke, et al.
Publicado: (2011)

OR6-001 - S100A12 as pro-inflammatory TLR4 ligand
por: Kessel, C, et al.
Publicado: (2013)

Neuroendocrine breast carcinomas of aged women may express apocrine differentiation markers
por: Sapino, A, et al.
Publicado: (2001)

Enrichment of CD8+ CD28- cytotoxic T cells in circulating lymphocytes of patients with ankylosing spondylitis
por: Schirmer, M, et al.
Publicado: (2001)

Treatment of breast cancer in elderly patients
por: Zappulla, E, et al.
Publicado: (2009)

Plasma-cell like morphotype with loss of CD3 expression by Th1 cytokine producing cells
por: Page, G, et al.
Publicado: (2003)

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics
por: Oakes, SR, et al.
Publicado: (2012)

IGFBP-7 expression in human breast cancer and association with proliferation and cell cycle aberrations
por: Östlund, H, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_1f3pupr08ik40eg2khvebucmts